The Scientist - Home

In the wake of reports of CRISPRed babies born in China, a bipartisan resolution “opposes the experiments that resulted in pregnancies using genome-edited human embryos.”

Deaths attributed to the disease have outpaced those from Ebola this year.

Our survey of seminars in biology and chemistry shows that women ask fewer questions than men. We propose ways to change that.

Some variants implicated in the disease are also linked to other psychiatric disorders.

Hundreds of CRISPR patents have been granted around the world, and the number of applications continues to grow at a rapid pace.

Sensors encapsulated with oral chemotherapy drugs help patients and physicians keep track of treatments.

Researchers use 3-D printing technology to construct a brain cancer model that accurately recapitulated in vivo biology and predicted patient drug responses.

By unraveling the molecular underpinnings of inherited blood disorders, the Boston Children’s Hospital researcher has provided the basis for therapies now being tested for beta-thalassemia and sickle cell disease.

How we talk about the coming revolution in clinical care matters as much as the need to involve all types of people in the process.

Scientists are pretty sure they know where the seaweed is coming from. Now they want to know why it’s here.

The three-dimensional cell cultures are still in the development phase, but researchers are excited about their use to predict patients’ responses to various treatment options.

Robert Guthrie’s blood test for the metabolic disorder phenylketonuria launched a worldwide movement to screen every baby for the disease soon after birth.